Hey Rizz,
I am still bullish on GLCO to .10 for sure, at least. I just got impatient and sold early and already missed out on the initial gains I was looking for, so I've moved on.
*** Alerting EAPH at .036 ***In addition to announcing a partnership with GLCO to sell their new anti-aging hemp cream on their website, EAPH has been busy trying to acquire a Canadian marijuana grow operation. This ticker is up 1700% in 3 months, but off it's 52 week high pretty significantly. Couple with this huge news last week, I believe it is being intentionally held down:
Easton Pharmaceuticals Announces Upgrade to Its Proposal With Vodis
Innovative Pharmaceuticals, Signs Additional LOI and Partnership
Agreement Towards Medical Marijuana Acquisition(s), Places Funds in
Escrow Towards a Final Agreement and Closing
TORONTO, ON--(Marketwired - Mar 3, 2014) - Easton Pharmaceuticals
Inc. (OTC: EAPH) a specialty pharmaceutical company that owns, designs,
develops, and markets an array of topically-delivered drugs and
therapeutic / cosmetic healthcare products, today announces it has
revised its offer to Vodis Innovative Pharmaceuticals in the companies
quest to close on an acceptable agreement towards its medical marijuana
initiatives. Additionally, Easton has signed a Letter of Intent with a
private Ontario Canada based company presently producing organic medical
marijuana, as well as executing an additional letter of intent towards a
partnership agreement for the purchase of various marijuana producing
companies who have all filed applications with health Canada for medical
marijuana distribution and growing licenses under the MMPR (Medical
Marijuana For Medical Purposes Regulations) which includes a revenue
producing acquisition.
In order to keep its shareholders abreast on initiatives,
Easton has decided to announce it has been in negotiations with Vodis
Innovative pharmaceuticals, a private British Columbia based company who
have received pre license approval on medical marijuana from health
Canada under MMPR regulations. Vodis is considered to be one of only 8
companies thus far who have received approval, but who now are mandated
to meet and pass certification on facilities as per their application
prior to receiving a license. Vodis is considered an established
producer of marijuana and have received awards for their quality of
cannabis and are considered to possess high technology growing equipment
including LED lighting. Vodis continues to be in negotiations with
Easton pharmaceuticals to work towards what is hoped to be a final
agreement. Easton Pharmaceuticals previously forwarded an initial
proposal which was revised on Feb. 28 to where Easton Pharmaceuticals
has more than doubled its proposal to where it has now agreed to advance
an up front cash payment of $500,000 to Vodis plus a commitment for
additional funds through cash and / or the Issuance of common stock in
Easton pharmaceuticals.
Although the company believes it can come to terms and sign a
final definitive agreement with Vodis, concurrent with its continuing
negotiations, Easton Pharmaceuticals in its pursuit and intent to enter
into the medical marijuana industry are preparing for alternate
contingencies in the case that Vodis and Easton are unable to mutually
agree. As a result, Easton announces it has signed an agreement with a
consortium for the acquisition of up to five companies who have all
applied for medical marijuana licenses with health Canada. One of the
five companies and the main focus, is a company that has been generating
revenues growing marijuana over the last few years. Additionally,
Easton Pharmaceuticals has signed a Letter Of Intent with a private
Ontario Canada based company who are currently growing organic marijuana
plants, have submitted their own application to Health Canada for
medical marijuana and are awaiting word on an imminent decision. As a
condition to closing for all negotiations, Easton Pharmaceuticals has
agreed to put up to $500,000 cash in escrow. Until such time as
discussions with Vodis have ceased, the Company is not able to disclose
any further details.
-------------
Plays for this next week, so many tickers with good news pending:
1) MDRM - the website PR was just a teaser of what is to come... still awaiting on audited financials (confirmed) and potential Canadian MJ operation (strong STRONG rumor)
2) TTDZ - After seeing two PRs last week, I see that as just the beginning of TTDZ's PR media blitz. After two months of silence, the company has spoken up in a big way. As I alluded to in my previous post, it is my belief TTDZ has partnered up with the Stanley Brothers out of Colorado to create a CBD Oil monopoly... I would not be entirely unsurprised to hear that TTDZ has added one of the Brothers to their Board of Directors, and to hear more news soon.
2) EAPH - going big here. I believe this follows in the same path as ATTBF and ENTR with Canadian grow ops and begins to trade above .10 in the near future, .25 in the next couple of months.
3) STBV this company is almost done diluting the crap out of their shareholders. I believe the bleeding has stopped, and it begins its rise to the double zeros .00xx this week and next. It won't be going to .0001, I'll just say that.
4) FWDG Still waiting for the volume to come in here, such a sleeper...
5) GDSM I was in here originally at .0012 and nearly doubled down at .0020. I'm not going anywhere. It bounced it's head nicely off .0012 several times this past week. The CEO butchered the momentum, plain and simple. Just look at it as an opportunity to jump back in. I think we hear news by end of this week.
6) UNQT Still strong volume and rumors swirling... I think we hear a PR this week or next week. Beyond the end of next week, I will sell if we don't hear news. If we do hear ganja news, this could be my first 20 bagger.
Kicking myself over CWIR had that one marked to buy on Monday, then the news with ENTI on Friday changed all that, and it went nuts. Also kicking myself over STEV, did not buy, and up nearly 300% since I first alerted...
TOO MANY TICKERS, AHHHHHHH
.
Hot Forum Topics
